For adults with moderate to severe rheumatoid arthritis (RA) in whom TNF blockers did not work well.

If you’re still experiencing RA symptoms after a TNF blocker like HUMIRA® or ENBREL®,



and may help

RINVOQ is a JAK inhibitor

Proven in clinical studies, RINVOQ can:

  • Tame joint pain, swelling, and stiffness
  • Stop further irreversible joint damage
  • Make it easier to do everyday things
  • Significantly reduce fatigue
RINVOQ Bottle and Once-Daily Pill

RINVOQ is a once-daily pill, not an injection

HUMIRA® is a registered trademark of AbbVie Inc. ENBREL® (etanercept) is a registered trademark of Immunex Corporation in the US.

Understanding the possible side effects of RINVOQ

Consider the benefits and risks of taking RINVOQ to make an informed treatment choice with your rheumatologist.

>95% of people with insurance are covered for RINVOQ

>95% of people with self- or employer-provided insurance plans or Medicare Part D are covered for RINVOQ. National commercial and Medicare Part D formulary coverage as of June 2023.



People have been prescribed RINVOQ for RA in the US since 2019

10 years

RA clinical trial experience

Meet people
taking RINVOQ

Hear how real patients stand up
to RA with RINVOQ.

Clipboard Icon

Get Mission Ready

Create your game plan to take on RA with tools that will help you assess your symptoms, set goals for the future, and prepare for your next rheumatologist appointment.

Are you getting relief?

If you haven’t seen significant improvement in your RA pain, swelling, and stiffness after 3 months with your current treatment, it may be time for a treatment change.

To see how RA is affecting you, take the RA disease activity assessment today >

RINVOQ Digital Brochure

Read up on RINVOQ

The RINVOQ digital brochure is your go-to guide to taking on rheumatoid arthritis.

Book Icon

Share your RINVOQ story

Share your experience with RINVOQ to help inform and inspire others. To participate, please email us at or call 877-861-6180.

ENBREL® (etanercept) is a registered trademark of Immunex Corporation in the US.